Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Adhesive patch containing and delivering essential and balsamic oils for the symptomatic treatment of the common cold and nasal congestion More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Compatible Permeation Enhancement Excipients: Enhancing Transmucosal and Transdermal Drug Delivery More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Site-specific localization and highly efficient drug delivery. More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
A novel chemoenzymatic method for producing a key building block of Tamiflu (oseltamivir). More
Patent pending prebiotic suppositories deliver prebiotics directly to the vagina, supporting growth of protective vaginal flora and discouraging overgrowth of pathogenic bacteria and yeast More
We have developed the tablet for suspension containing Amoxicillin and Potassium Clavulanate, equivalent to GSK’s Augmentin® Suspension, This product is much superior to the reference product in terms of stability during storage and don’t require stor More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Jan 2011 - 124 pages - $1,740
Dec 2010 - 28 pages - $500
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Nov 2011 - 7 pages - $3,835
Oct 2011 - 150 pages - $3,500
Jun 2009 - 110 pages - $1,040
Jun 2006 - 1458 pages - $2,495
May 2009 - 131 pages - $3,800
Your selection
Browse By
- Industry sector
- Intravesical
- Nasal
- Nasal topical
- Ophthalmic
- Oral liquid
- Oral solid
- Otic
- Parenteral
- Pulmonary
- Rectal
- Systemic
- Topical
- Vaginal
- Therapeutic target
- Bacteria or virus
- Bioterrorism
- Diseases
- Hepatitis (other)
- Nosocomial infections
- Parasitic diseases
- Treatments
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us